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ATP1A2 Mutations in Migraine:
Seeing through the Facets of an Ion
Pump onto the Neurobiology of
Disease
Thomas Friedrich*, Neslihan N. Tavraz and Cornelia Junghans
Department of Physical Chemistry/Bioenergetics, Institute of Chemistry, Technical University of Berlin, Berlin, Germany
Mutations in four genes have been identified in familial hemiplegic migraine (FHM), from
whichCACNA1A (FHM type 1) and SCN1A (FHM type 3) code for neuronal voltage-gated
calcium or sodium channels, respectively, while ATP1A2 (FHM type 2) encodes the α2
isoform of the Na+,K+-ATPase’s catalytic subunit, thus classifying FHM primarily as an
ion channel/ion transporter pathology. FHM type 4 is attributed to mutations in the PRRT2
gene, which encodes a proline-rich transmembrane protein of as yet unknown function.
The Na+,K+-ATPase maintains the physiological gradients for Na+ and K+ ions and
is, therefore, critical for the activity of ion channels and transporters involved neuronal
excitability, neurotransmitter uptake or Ca2+ signaling. Strikingly diverse functional
abnormalities have been identified for disease-linked ATP1A2 mutations which frequently
lead to changes in the enzyme’s voltage-dependent properties, kinetics, or apparent
cation affinities, but some mutations are truly deleterious for enzyme function and
thus cause full haploinsufficiency. Here, we summarize structural and functional data
about the Na+,K+-ATPase available to date and an overview is provided about the
particular properties of the α2 isoform that explain its physiological relevance in electrically
excitable tissues. In addition, current concepts about the neurobiology of migraine,
the correlations between primary brain dysfunction and mechanisms of headache
pain generation are described, together with insights gained recently from modeling
approaches in computational neuroscience. Then, a survey is given about ATP1A2
mutations implicated in migraine cases as documented in the literature with focus
on mutations that were described to completely destroy enzyme function, or lead
to misfolded or mistargeted protein in particular model cell lines. We also discuss
whether or not there are correlations between these most severe mutational effects
and clinical phenotypes. Finally, perspectives for future research on the implications of
Na+,K+-ATPase mutations in human pathologies are presented.
Keywords: familial hemiplegic migraine, Na+,K+-ATPase, human ATP1A2, neuronal hyperexcitability, protein
expression, protein stability, protein targeting, structure-function studies
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Na+,K+-ATPase IN FAMILIAL HEMIPLEGIC
MIGRAINE AND OTHER INHERITED
DISEASES
Migraine is a particularly disabling pathology with a high cost for
human society. The “Atlas of Headache Disorders and Resources
in the World 2011” issued by the WHO reported that about 10%
of the world’s population suffer from migraine, with three times
more women affected than men, causing 190 million days lost
from work every year in Europe alone, which ranks migraine in
the fourth place among neurological disorders with an estimated
annual cost of about 116 billion Euros.
Migraine frequently appears with perceptional or
somatosensory disturbances, which are called “aura” symptoms.
These can include alterations in the field of vision (scotoma),
flashes, strange smells or sounds, but also tingling, numbness
or partial paresis. Familial Hemiplegic Migraine (FHM) is an
autosomal dominantly inherited form of migraine with aura
(MA, as opposed to migraine without aura, MO), in which the
accompanying aura symptom of the typical half-sided headache
is transient motor weakness (hemiparesis) that is frequently
accompanied by other cortical symptoms. Four FHM types
have been identified by human geneticists, from which FHM
type1 (FHM1) and type 3 (FHM3) affect the genes coding
for the neuronal voltage-gated P/Q-type calcium channel’s
α-subunit (CACNA1A) (Ophoff et al., 1996) or the neuronal
voltage-gated sodium channel’s α-subunit (SCN1A) (Dichgans
et al., 2005), respectively. FHM type 2 (FHM2) is caused by
mutations in the ATP1A2 gene (De Fusco et al., 2003), which
encodes the isoform 2 of the human Na+,K+-ATPase’s large
catalytic α-subunit, which in the adult central nervous system
(CNS) is mainly expressed in astrocytes. Recently, a fourth FHM
gene, PRRT2, has been identified (Riant et al., 2012), which
encodes a proline-rich transmembrane protein of still unknown
function. The PPTR2 protein was suggested to interact with
the synaptosomal-associated protein 25 (SNAP-25), a t-SNARE
protein, which accounts for the specificity and execution of
synaptic vesicle fusion with the plasma membrane (Rizo and
Südhof, 2002).
Hemiplegic migraine and MA/MO also occur as a
comorbidity in proximal renal tubular acidosis (pRTA) patients
carrying certain homozygous mutations in the SLC4A4 gene
(encoding the Na+-HCO−3 cotransporter NBCe1), in which
mutations in the other known FHM-related genes were ruled
out (Suzuki et al., 2010). The NBCe1B splice variant is expressed
in several tissues including brain, and its transport activity
in astrocytes is thought to modulate neuronal excitability by
regulating local pH (Chesler, 2003) suggesting that also defective
pH regulation in the brain may be a susceptibility factor in
hemiplegic and other types of migraine.
The Na+,K+-ATPase belongs to the large family of P-
type ATPases (Axelsen and Palmgren, 1998). The minimal
unit is composed of a large catalytic α-subunit (∼1020
amino acids, see Section Functional Insights Gained from
Structural Studies) and a smaller, ancillary β-subunit (∼300
amino acids, one transmembrane domain (TM) with a heavily
glycosylated ectodomain). The β-subunit is a mandatory feature
of K+-countertransporting P2C-type ATPases, which assists in
proper folding, assembly and targeting of the holoenzyme (Jaunin
et al., 1993), and modulates cation affinities (Crambert et al.,
2000). According to molecular modeling studies, the particular
β-isoform serves in tuning the pump depending on its individual
tilt angle (Hilbers et al., 2016) by differentially stabilizing
the E1P(3Na+) state. There is a still unresolved controversy
about the existence of higher oligomeric states (see Donnet
et al., 2001; Clarke, 2009; Shattock et al., 2015; and references
therein), which, if true, would allow for speculations about
possible dominant-negative effects in the heterozygous state of
affected patients. Based on earlier biochemical evidence (Forbush
et al., 1978), a third, auxiliary γ-subunit was identified (66
amino acids, one TM) (Mercer et al., 1993), which belongs to
the class of FXYD-domain containing ion transport regulator
proteins (Sweadner and Rael, 2000) and is now classified as
FXYD2. The FXYD family, named after the invariant amino
acid motif FXYD, comprises seven members in humans (FXYD1,
or phospholemman; FXYD2, or Na+,K+-ATPase γ-subunit;
FXYD3, or Mat-8; FXYD4, or corticosteroid hormone-induced
factor, CHIF; FXYD5, or “related to ion channel”, RIC, also
termed dysadherin; FXYD6, or phosphohippolin; FXYD7), from
which all but FXYD6 were shown to associate with Na+,K+-
ATPase α/β-complexes and exerted distinct effects on pump
function (see reviews by Garty and Karlish, 2006; Geering,
2006). Since the various FXYD isoforms have different tissue
distribution and functional effects, with prominent expression
in electrically excitable or fluid- and solute-transporting tissues,
these proteins act as tissue-specific modulators of Na+,K+-
ATPase in order to fine-tune its kinetic properties according
to the tissue’s requirements or physiological state. In the brain,
FXYD1, -6, and -7 are the most abundant isoforms (Garty and
Karlish, 2006).
Four α-isoforms exist in humans, from which α1 is
ubiquitously expressed and therefore the most indispensable
isoform for cellular ion homeostasis, volume regulation,
excitability etc. The α2-isoform (ATP1A2) is particularly high
expressed in skeletal muscle (SM), but also heart and vascular
smooth muscle (VSM) express it. In the adult central nervous
system (CNS), α2 is mainly found in astrocytes, whereas α3
(ATP1A3) is neuronal-specific, and α4 has only been found
in testis (spermatozoa) (see Blanco et al., 1999; Larsen et al.,
2014; Shattock et al., 2015 and references therein). Two other
types of human inherited diseases have been linked to α-
subunit isoforms. Mutations in the ATP1A3 gene cause Rapid
Dystonia Parkinsonism (RDP, DYT12) (de Carvalho Aguiar
et al., 2004), as well as Alternating Hemiplegia of Childhood
(AHC) (Heinzen et al., 2012). While the ATP1A1 gene for the
ubiquitously expressed α1-isoform is regarded as a susceptibility
locus in human essential hypertension (Glorioso et al., 2001),
congenital mutations in the gene have not been described
so far. However, somatic ATP1A1 mutations were detected
in aldosterone-producing adenomas (APA) and secondary
hypertension (Azizan et al., 2013; Beuschlein et al., 2013).
Functional studies of the ATP1A1 mutants showed loss of pump
activity, strongly reduced K+ affinity and augmented inward
proton leak currents (see next section) at physiological potentials
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and concentrations of Na+ and K+ (Azizan et al., 2013).
Furthermore, abnormal depolarization was observed in primary
adrenal adenoma cells (Beuschlein et al., 2013), which was
suggested to be the consequence of enhanced inflow of protons
rather than being caused by reduced Na+,K+ pumping (Azizan
et al., 2013). This may indirectly lead to enhanced Ca2+ signaling
and, consequently, enhanced aldosterone output (Beuschlein
et al., 2013). Another syndrome, renal hypomagnesemia type 2
(HOMG2), an autosomal dominant pathology with isolated renal
magnesium loss, is linked to mutations in the γ-subunit’s FXYD2
gene. Evidence has accumulated that FXYD2 mutations cause
misrouting of the Na+,K+-ATPase, which would lead to loss of
plasma membrane protein in the kidney (Meij et al., 2000).
At least indirectly associated with Na+,K+-ATPase is Long
QT Syndrome type 4 (LQT4), a type of cardiac arrythmia with
a prolonged QT-phase in electrocardiograms (Lu and Kass,
2010) that frequently causes cardiac fibrillation and sudden
death. Unlike other LQT types, LQT4 does not relate to genes
of cardiac ion channels, but affects the ANK2 gene encoding
ankyrin-B. Ankyrin-B serves as a scaffold protein responsible for
proper targeting of Na+,K+-ATPase, the Na+,Ca2+-exchanger
and the InsP3 receptor to T-tubules/sarcoplasmic reticulum
microdomains in cardiac muscle cells (Mohler et al., 2005). Thus,
not only molecular function, but also cellular processing must be
considered in the neurobiology of disease.
FHM2 cases frequently share comorbidity with other
neurological disorders, such as seizures, AHC and even epilepsy
(Supplementary Table 1). This overlap is intriguing, since all
these phenomena are linked to deficient regulation of the cortical
excitatory/inhibitory balance (Pietrobon and Moskowitz, 2013).
Most of the aura symptoms are caused by the phenomenon
of Cortical Spreading Depression (CSD) (Leão, 1944) or CSD-
like events that are characterized by a spreading front of
excitation, which is followed by a long-lasting depression
(Moskowitz et al., 2004). Whereas CSD spreads slowly over the
neocortex, epilepsy is characterized by rapidly circulating waves
of neuronal hyperexcitation. This pathophysiological overlap
raises the question, which parameters determine the evolution of
such a highly non-linear excitable system as the neocortex into
one or the other hyperexcitation pattern (Ullah et al., 2015).
Na+,K+-ATPase: FUNCTION AND
STRUCTURE
Functional Properties of the
Na+,K+-ATPase
The Na+,K+-ATPase is an electrogenic, primary active
transporter protein, which energizes the membrane of all
animal cells with the characteristic electrochemical gradients for
Na+ and K+ ions. These gradients are pivotal for the activity of
secondary active transporters such as the Na+,Ca2+-exchanger
(NCX), neurotransmitter uptake transporters or voltage-gated
Na+ and K+ channels involved in electrical excitability. The
mechanism of function is generally expressed in the form of
the Post-Albers scheme (Albers, 1967; Post et al., 1972), as
shown in Figure 1. In each reaction cycle, the Na+,K+-ATPase
transports three Na+ ions out of and two K+ ions into the cell
upon hydrolysis of one ATP molecule. The enzyme undergoes
cyclic interconversions between two principal conformations, E1
and E2 and phosphorylated intermediates thereof, E1P and E2P,
in which a phosphate group from ATP is covalently attached to a
critical aspartate residue within the SDKTGTLT motif (see next
section about structural details). Upon binding of three Na+ ions
from the intracellular side in the ATP-bound E1 conformation,
the phosphorylated intermediate with three occluded Na+ ions,
E1P(3Na+), is formed. This is followed by a conformational
change to the E2P(3Na+) conformation, from which Na+ ions
are extracellularly released. Because of the increased affinity for
K+ in this configuration, two K+ ions bind subsequently from
the extracellular side, which triggers dephosphorylation and
occlusion of two K+ ions in the E2(2K+) state. After another
conformational change to E1(2K+), the K+ ions dissociate
into the cytoplasm, a process that is speeded up by ATP
binding.
Also included in Figure 1 are inhibitors of the Na+ pump.
Ouabain (or g-strophanthin) belongs to the family of cardiotonic
steroids, from which digitalis (g-strophantidin) from the red
foxglove Purpurea officinalis was in medicinal use against
dropsy and cardiac insufficiency for centuries (Withering, 1785).
Ouabain is used to isolate Na+,K+-ATPase functional activity
in cells or tissue preparations and was a prerequisite for
the identification of the “sodium- and potassium-transporting
adenoside triphosphatase” by Chemistry Nobel Prize awardee
Jens Christian Skou (Skou, 1957). The compound arrests the
Na+ pump with high affinity (with IC50 or KD values in
the range of tens of nM for human Na+,K+-ATPase α1-,
α2-, or α3-subunits in complex with human β1-subunit, (see
Katz et al., 2010; Weigand et al., 2014a) and references
therein) by binding from the extracellular side to the E2P
conformation, and this interaction competes with extracellular
K+ binding. In contrast, (ortho-)vanadate (VO−4 ) blocks the
pump from the intracellular side with nanomolar affinity. With
its similarity to the phosphate (PO3−4 ) anion and its trigonal
bipyramidal structure, it serves as a transition state analog for
the hydrolytic dephosphorylation of the phosphointermediate.
Vanadate arrests the Na+ pump in the E2P(3Na+) form (Glynn,
1985). Oligomycin, a macrolide antibiotic from Streptomyces,
also inhibits the Na+,K+-ATPase (Glynn, 1985) by promoting
the occlusion of Na+ ions in the E1P form, and decreases the rate
of Na+ release from the phosphoenzyme, thereby inhibiting the
E1P→E2P interconversion (Glynn, 1985; Skou, 1990).
The sequential translocation of Na+ and K+ ions
requires strict cation specificity of the phosphorylation and
dephosphorylation reactions, mutual changes of the apparent
affinities for Na+ and K+ and alternating access of the cation
binding sites to the extra- and intracellular medium. Active
transport by an ion pump also requires the operation of two
“occlusion gates” (indicated by a blue and red bar in Figure 1)
shielding the bound cations from the extra- or intracellular
medium, which must never be open simultaneously (Gadsby,
2009). According to the 3Na+/2K+ stoichiometry, the Na+,K+-
ATPase produces an outward movement of one positive charge
per cycle and generates a pump current. The major electrogenic
event has been shown to take place during extracellular release
(or reverse binding) of Na+ (Fendler et al., 1985; Gadsby et al.,
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FIGURE 1 | The Post-Albers reaction mechanism of the Na+,K+-ATPase. See text for details.
1985; Nakao and Gadsby, 1986; Gadsby and Nakao, 1989;
Rakowski et al., 1991; Rakowski, 1993; Wuddel and Apell, 1995)
within a sequence of coupled partial reactions, which is underlaid
in yellow in Figure 1. Electrogenicity arises from passage of Na+
ions through a narrow, high-field “access channel” to/from
the extracellular space (Läuger, 1979; Gadsby et al., 1993;
Hilgemann, 1994; Sagar and Rakowski, 1994; Rakowski et al.,
1997; Holmgren et al., 2000; Holmgren and Rakowski, 2006).
This term, combined with the notion of its “fractional depth”, is
frequently used to denote that an ion passes a certain fraction of
the transmembrane electric field in order to reach or exit from its
binding site. In the same way as the existence of a positive slope of
the stationary current-voltage (I-V) curve in the negative voltage
range indicates electrogenic extracellular Na+ release (or reverse
binding) (Nakao and Gadsby, 1989), the negative slope in the I-V
curve at positive voltages (Rakowski et al., 1991) suggests that
also K+ ions bind within an extracellular access channel, albeit of
smaller fractional depth (see Section Electrophysiological Assays:
The Two-Electrode Voltage Clamp for more details). There
might well be other steps in the catalytic cycle, which contribute
to the total electrogenicity of the Na+ pump, such as intracellular
Na+ binding, as shown by Pintschovius et al. (1999) as well as
Apell and Karlish (2001).
Electrophysiology has elucidated another functional detail
of the Na+,K+-ATPase, namely the ouabain-sensitive “leak
currents”, which were first observed at negative voltages in the
absence of extracellular Na+ and K+, and are augmented by
extracellular acidification. Initially reported by Rakowski et al.
(1991) and later investigated in more detail by Efthymiadis et al.
(1993), Wang and Horisberger (1995), Rettinger (1996) and Li
et al. (2006), this property has for a long time been merely
recognized as a footnote in Na+ pump research, until structural
and functional evidence highlighted the critical role of protons in
the transport cycle, as indicated bymutations that interfere with a
C-terminal pathway for protons (see Section Functional Insights
Gained from Structural Studies) to access the cation binding
pocket (Morth et al., 2007; Poulsen et al., 2010). Recently, it was
demonstrated that the proton leak inward current is a property
inherent to Na+,K+-ATPase that also flows at physiological K+
and Na+ concentrations and membrane potentials (Mitchell
et al., 2014; Vedovato and Gadsby, 2014), even in native
cells, i.e., in the presence of the pump’s normal regulatory
subunit phospholemman, which is prevalent in cardiac tissue
(Mitchell et al., 2014). Vedovato and Gadsby concluded that
inward proton leak exploits the reversibility of a subset of
conformational changes associated with extracellular Na+ release
from the phosphorylated enzyme. Although such a back-step of
phosphorylated Na+,K+-ATPase that enables proton import is
not required for completion of the 3Na+/2K+ transport cycle,
it readily occurs during Na+,K+ transport when external K+
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ion binding and occlusion are retarded, and it occurs more
frequently when the probability for extracellular proton access
is increased by acidification (Vedovato and Gadsby, 2014). The
protons presumably pass through the Na+-selective binding site
III (whichmay be in fact two sites, see Section Functional Insights
Gained from Structural Studies) via the carboxylates of Glu-958
to Asp-930 via the intervening hydroxyl of Tyr-775 (ATP1A2
numbering), which is distinct from the principal pathway of the
Na+ and K+ ions passing through binding site II. From the
simultaneous occurrence of Na+,K+ exchange and H+ import
during the same conformational cycle of a single molecule,
the Na+,K+-ATPase classifies as a hybrid transporter, although
the physiological or pathophysiological significance of pump–
mediated proton inflow still has to be clarified (Vedovato and
Gadsby, 2014). By performing experiments over an expanded
range of extracellular pH (pHo) values and meticulous ion
competition assays, Mitchell et al. delineated a previously
unrecognized inhibitory action of extracellular protons on the
leak current, which occurs in addition to the pHo-induced leak
stimulation (Mitchell et al., 2014). Based on the strong voltage
dependence of the pHo-induced leak stimulation, these authors
concluded that protons leak through the site responsible for
strong Nao- and voltage-dependent inhibition of pump current,
which must be site III, in agreement with (Vedovato and Gadsby,
2014). The pHo-dependent inhibition of the leak, although
profoundly enhanced by decreasing pHo, was nevertheless only
weakly voltage-dependent, similar to the inhibition by Na+o or
extracellular K+ binding, suggesting that inhibition of the leak
current by external cations (H+, Na+ or K+) requires binding to
sites I and II that are not responsible for the Na+,K+-ATPase’s
voltage dependence (Mitchell et al., 2014).
The inward current was found to be augmented by mutations
at the Na+,K+-ATPase’s C-terminus (Yaragatupalli et al., 2009;
Meier et al., 2010; Poulsen et al., 2010; Vedovato and Gadsby,
2010; Paulsen et al., 2012), and sometimes further enhanced
with increasing extracellular [Na+], which conforms with an
earlier proposal that Na+ ions might flow along what has been
referred to as the Na+,K+-ATPase “leak” pathway, a process
that is promoted by extracellular protons (Vasilyev et al., 2004).
The studied C-terminal mutations frequently correlate with
drastic decreases in the apparent affinity for extracellular and
intracellular Na+ (Toustrup-Jensen et al., 2009, 2014), because
C-terminal mutations interfere with Na+ binding site III.
Whether or not Na+,K+ pump-mediated proton uptake plays
a physiological or pathological role is still unclear. Vedovato
and Gadsby pointed out, that already at physiological pHo,
and even more so at decreased pHo in a pathophysiological
situation, the Na+,K+ pump will import one or several protons
downhill in each ATPase transport cycle. Thus, proton inward
leak might significantly accompany Na+,K+ pumping at the
normal negative resting potentials of neurons as well as
cardiac and skeletal muscle cells, if extracytoplasmic pH became
sufficiently low, as e.g., during vigorous muscle exercise, or in
cardiac or cerebral ischemia, since Na+,K+-ATPase densities
in muscle, nerve, and heart can be very high (≥1000µm2). It
is also conceivable that the known limitation of H+-ATPase-
mediated acidification of early endosomes by endocytosed
Na+,K+-ATPase might be the direct consequence of Na+,K+
pump-mediated flow of protons from the endosome lumen to
the cytoplasm (Vedovato and Gadsby, 2014). The importance
of cortical pH regulation is underlined by the involvement
of certain homozygous mutations in the NBCe1 Na+-HCO−3
cotransporter, which is expressed in astrocytes, in pRTA patients
that additionally suffer from hemiplegic migraine (Suzuki
et al., 2010). Glial cell depolarization usually results from
elevated extracellular [K+], which causes glial cell acid secretion
via inward electrogenic Na+-HCO−3 cotransport, resulting in
depolarization-induced alkalosis (DIA) in the cytoplasm of glial
cells (Chesler, 2003). The extracellular acidosis that occurs
simultaneously to DIA makes the surrounding neuronal cells
less excitable because excitatory NMDA receptors are blocked
by protons (Suzuki et al., 2010). Therefore, extracellular acidosis
suppresses neuronal excitability, and the reduction of DIA
due to enhanced proton inward transport by mutant glial
Na+,K+-ATPase could also create a positive feedback loop of
increased neuronal activity leading to further NMDA-mediated
neuronal hyperactivity, depolarization of brain cells, and CSD
(Suzuki et al., 2010). Although increased proton leak has only
been reported for the R937P mutation in ATP1A2 (Poulsen
et al., 2010), this may not be an isolated observation, since
no other ATP1A2 allele has so far been scrutinized for altered
proton leak.
Functional Insights Gained from Structural
Studies
For the Na+,K+-ATPase, high-resolution structures of different
reaction cycle intermediates are available, which provided an
atomic-level understanding of active cation transport coupled to
enzymatic catalysis. Structures include the Rb+-occluded E2P-
like conformation [Rb+2 ]E2·MgF
2−
4 (Morth et al., 2007), which
was further refined in the E2·2K+·Pi (also stabilized by MgF
2−
4 )
structure that revealed the full arrangement of the β-subunit
(Shinoda et al., 2009), the low-affinity ouabain- and 2K+-bound
E2·2K+·Pi (also stabilized by MgF
2−
4 ) structure (Ogawa et al.,
2009), the high-affinity ouabain-bound E2P-like state with Mg2+




+ structure (stabilized with AlF−4 )
of an intermediate preceding the Na+-occluded E1P(3Na+)
state (Kanai et al., 2013), and a comparable [Na+3 ]E1P-ADP
state in complex with AlF−4 , with Na
+ saturation stabilized
by oligomycin (Nyblom et al., 2013). These structural data,
together with the wealth of intermediate structures determined
for the related SERCA Ca2+-ATPase from sarcoendoplasmic
reticulum (Olesen et al., 2007), provide a comprehensive
concept of the catalytic mechanism carried out by the
Na+ pump.
Figure 2 shows the arrangement of the α-, β- and γ-
subunit of the Na+,K+-ATPase in the 2Rb+-bound E2P-like
conformation (Morth et al., 2007). Several distinct domains
can be distinguished on the α-subunit, with 10 TM segments
forming the TM domain harboring the coordination sites for
cations and the central TM5 helix, which extends into the
central P (phosphorylation) domain. The P domain harbors
the P-type ATPase consensus motif 373SDKTGTLT380 with the
intermediately phosphorylated Asp-374 (all numbering refers to
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human ATP1A2), which is surrounded by the 612MVTGD616 and
713DG(V/M)ND717 motifs and the critical Lys-605. Nucleotide
binding occurs in the N domain, and the A (actuator) domain
serves as an anchor for the movement of the N domain by
performing a hinge-like movement during the conformational
cycle to bring the conserved 217TGES220 motif into close
proximity with 612MVTGD616 to expedite dephosphorylation.
Movement of the A domain also entails a piston-like movement
of TM helices 1 and 2. The crystal structures also highlighted
a particularly crucial arrangement of the enzyme’s C-terminal
sequence 1013WVEKETYY1020. The first part of this motif
assumes an α-helical structure accommodated between the TM
of the β-subunit and the TM7 and TM10 helices, and the two
terminal tyrosines project into a binding pocket between TM7,
TM8, and TM5, with the terminal Tyr-1020 interacting with Lys-
770 on TM5 and Arg-937 in the loop connecting TM8 and TM9
(Morth et al., 2007). Deletion of the terminal KETYY sequence
resulted in a 26-fold reduction of Na+ affinity, reminiscent of
the effect of mutations of putative Na+ coordinating residues.
This has prompted investigations of the functional importance
of C-terminal residues by studying deletions, mutations of
the terminal tyrosines, or C-terminal extensions. These studies
showed that alterations in the C-terminal sequence entail drastic
decreases in Na+ affinity and enhance the propensity of the
mutant pumps to permit inward proton leak (Yaragatupalli et al.,
2009; Meier et al., 2010; Poulsen et al., 2010; Vedovato and
Gadsby, 2010, 2014; Paulsen et al., 2012). This has given rise to the
concept that the C-terminal pathway occupied by the terminal
tyrosines defines a mandatory access route for intracellular
protons to the Na+ binding site III to bring about stoichiometric
3Na+/2K+ transport, in which Arg-937 and Asp-923 play a
critical role (Poulsen et al., 2010).
From the two “common” cation binding sites, site I is made
up from five oxygen atoms (from Thr-776 main chain, and from
Ser-779, Asn-780 (all TM5), and Asp-808 (TM6) side chains), and
one water molecule, whereas site II is coordinated by the main
chain carbonyls of Val-327, Ala-328, and Val-330 (all TM4) and
the side chain oxygens of Asn-780, Glu-783 (TM5) and Asp-808
(TM6), and possibly Glu-332 (TM4) (Shinoda et al., 2009). Of
note, the TM5 helix is unwound at Asn-780 to create sufficient
space for cation coordination. The unwinding is due to Pro-782;
both amino acids reside in the highly conserved 779SNIPE783
motif. In the two E1·P·ADP·3Na+-like structures, the geometry
for Na+ coordination at the two “common” sites is essentially the
same, with similar TM5 helix unwinding. Regarding the location
of Na+ binding site III, the structure by Kanai et al. (2013)
identified two slightly different locations in the two protomers of
the crystallographic unit, and the study by Nyblom et al. (2013)
had to resolve a similar ambiguity by proposing two sites, IIIa
and IIIb, from which site IIIa is surrounded by Glu-958, Tyr-
775, and Thr-811, and site IIIb adjacent to Thr-778, Gln-858,
Gln-927, and Asp-930, with a sufficiently clear electron density to
identify IIIb as primary Na+ binding site III. Mutational analysis
and electrophysiology suggested that site IIIa is a transient Na+
binding site during extracellular Na+ release. The latter was
also inferred from proton leak currents of mutant enzymes (see
below), which showed that site IIIa mutations (Y775F, Q958A)
FIGURE 2 | Structure of the Na+,K+-ATPase (PDB code 3B8E; Morth
et al., 2007) and location of migraine-associated ATP1A2 mutations.
The domains of the cytoplasmic part are A (actuator; light orange), N
(nucleotide binding; orange) and P (phosphorylation; pink) domain,
transmembrane helices are depicted in gray, except for the about 70 Å-long
central TM5 helix (orange). The β- and γ-subunits are shown in magenta and
blue, respectively, two Rb+ ions in the cation binding pocket are shown as
purple spheres. Amino acids mutated in migraine cases as listed in
Supplementary Table 1 are shown in stick representation. More than 80% of
mutations fall into four clusters, one around the catalytic P domain, one in a
central region between P and TM domain, one within the extracellularly-facing
part of the TM domain, and one around the enzyme’s C-terminus.
permitted leak currents in the absence of extracellular Na+ but
with Na+ closing the leak, whereas site IIIb mutations (D930E
and Q858N) permitted leak currents with and without Na+. This
gave rise to the concept that protonation of Asp-930 is associated
with voltage-dependent release of Na+ from site IIIb via site IIIa
to the extracellular space. The proton leak current can occur
under conditions when either no Na+ ions are bound or when
only the two common sites are occupied by Na+ ions (Nyblom
et al., 2013), or, as later shown, by protons (Mitchell et al., 2014).
Then, site IIIa is accessible to an extracellular proton, which
upon application of negative voltage can move via site IIIb to
the cytoplasm, thus making site IIIa accessible for an extracellular
proton again, which eventually leads to a sustained inward proton
leak current. This notion was corroborated and refined by two
comprehensive electrophysiological studies (Mitchell et al., 2014;
Vedovato and Gadsby, 2014).
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THE HEADACHE OF ATP1A2 MUTATIONS:
NEUROBIOLOGY OF MIGRAINE
How can Na+,K+-ATPase dysfunction be linked to migraine?
In the case of CACNA1A and SCN1A mutations, functional
disturbances are typically gain-of-function effects, and mutated
channels, e.g., exhibit an abnormal residual activity in the
inactivated state, which leads to prolonged cation influx into
neurons, thus causing, inter alia, depolarization and lowering of
the activation threshold. Whether ATP1A2 mutations in FHM2
classify as gain- or loss-of-function phenomena is not that clear-
cut. While many mutations abolish or largely reduce Na+,K+
pumping implying loss-of-function, others are characterized by
subtle changes in voltage dependence (Supplementary Table 1).
In these cases, a shift of the pump current’s I-V curve may
entail loss-of-function in a particular voltage range, but gain-
of-function in another. From the viewpoint of Na+,K+-ATPase
cation transport, a first clue is obtained from the fact that
hyperkalemia is a known CSD and migraine trigger. Since the
transporter in neurons or astrocytes removes extracellular K+,
dysfunction of the pump can lead to elevated extracellular K+
levels, which cause depolarization and reduce the activation
threshold. But also Na+ extrusion by the enzyme is critical, since,
e.g., the activity of secondary active transporters depends on
the Na+ gradient across the membrane. First, the Na+,Ca2+-
exchanger (NCX1) utilizes Na+ import for the extrusion of Ca2+,
and failure to efficiently remove cytosolic Ca2+ during neuronal
activity leads to Ca2+ accumulation in intracellular stores, from
which it is then more heavily released during an action potential,
and again, hyperexcitability is the outcome. Second, excitatory
neurotransmitter uptake transporters (EAATs) also couple to
the Na+ gradient, and failure to remove neurotransmitters such
as glutamate from the synaptic cleft again results in sustained
hyperexcitability (see Figure 3).
It is generally accepted that cortical spreading depression
(CSD) is the neurophysiological correlate of migraine aura
(Pietrobon and Striessnig, 2003). Therefore, neurobiologists
split up the question concerning the pathogenic mechanism of
migraine into two parts: (1) What is the relation of ATP1A2
mutations to CSD, and (2), what are the links between CSD and
cortical pain perception? Although the existence of a “migraine
generator” in the brainstem has not been completely ruled out
(Pietrobon and Moskowitz, 2013), there is currently no doubt,
that CSD plays a central role in the pathophysiology of migraine.
From ATP1A2 Mutations to CSD:
The Glutamatergic Hypothesis
From clinical studies, it is known that neurophysiological
abnormalities in sensory information processing (which are
most intense 12–24 h before a migraine attack during the
premonitory phase, but disappear a few hours before or
during the attack) change in intensity in temporal relation
to the migraine episode. This suggests that some intrinsic
mechanism in the brains of migraineurs progressively increases
the dysfunction in central information processing and the
susceptibility to a migraine trigger. These mechanisms may lead
to the premonitory symptoms and, above a certain threshold
of cortical dysfunction in response to migraine triggers, may
eventually ignite CSD. Depending on the study, the cortex
of migraineurs is hyperexcitable as a consequence of either
enhanced excitation or reduced inhibition, or is hypoexcitable,
or has a lower preactivation level. Thus, also here, rather than
merely hypo- or hyperexcitability, defective regulation of cortical
excitability and the consequently reduced ability to maintain the
cortical excitatory/inhibitory (E/I) balance appears to underlie
abnormal sensory processing (Pietrobon and Moskowitz, 2013,
2014).
The analysis of experimental CSD in FHM knockin mouse
models suggests that CSD is a key migraine trigger, since both
FHM1 and FHM2 knockin mice showed a lower electrical
stimulation threshold for CSD induction and faster CSD
propagation (van den Maagdenberg et al., 2004, 2010; Leo
et al., 2011). In FHM1 knockin mice carrying the mild R192Q
mutation or the severe S218L mutation in CACNA1A, the
strength of CSD facilitation as well as the severity of the
subsequent neurological motor deficits and the propensity of
CSD to propagate into subcortical structures correlated with the
strength of the gain-of-function of the CACNA1A channel and
the severity of the clinical phenotype (van den Maagdenberg
et al., 2004, 2010). Interestingly, the velocity of propagation
and the frequency of CSDs elicited by local application of
high [K+] were larger in female than in male FHM1 mouse
mutants, in correspondence with the higher migraine prevalence
of females (Eikermann-Haerter et al., 2009). However, such
gender differences were not found in FHM2 knockin mice
carrying the (heterozygous) W887R mutation in ATP1A2 (Leo
et al., 2011). More importantly, the analysis of cortical synaptic
transmission in FHM1 knockin mice revealed differential effects
of FHM1 mutations at excitatory and inhibitory synapses:
Excitatory synaptic transmission on cortical pyramidal cells was
enhanced as a consequence of increased action potential-evoked
Ca2+ influx and increased glutamate release, and enhanced
short-term synaptic depression during trains of action potentials
was observed. In contrast, inhibitory neurotransmission at
cortical fast spiking interneuron synapses was not altered in
FHM1 knockin mice, although being initiated by P/Q-type
Ca2+ channels as well (Tottene et al., 2009). Although these
considerations were restricted to specific cortical subcircuits,
the differential effect of FHM1 mutations on excitatory and
inhibitory neurotransmission may produce hyperexcitation in
certain brain conditions, but may leave the excitatory/inhibitory
balance intact in others, consistent with the episodic nature
of the disease (Pietrobon and Moskowitz, 2013). The gain-of-
function of glutamate release at synapses of cortical pyramidal
cells can explain the facilitation of experimental CSD in FHM1
knockin mice, which supports a model of CSD initiation, in
which CACNA1A-dependent release of glutamate from cortical
pyramidal cell synapses and activation of NMDA receptors
play a key role in the positive feedback cycle that ignites
CSD (Pietrobon and Moskowitz, 2013). It was suggested that
excessive NMDA receptor-mediated glutamatergic transmission
following impaired clearance of glutamate by astrocytic processes
surrounding glutamatergic synapses (the “tripartite synapse” see
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FIGURE 3 | ATP1A2 and ATP1A3 in the tripartite synapse (Perea et al., 2009). Most glutamatergic synapses are in contact with astrocytic processes, which
express a high density of excitatory amino acid transporters (EAATs, e.g., GLT1, GLAST), which are crucial for the synaptic glutamate (Glu) clearance. In astrocytes,
glutamate is converted to glutamine by glutamine synthetase as part of glutamate recycling. Ion channels involved in electrical excitation are indicated by the
respective cations, Na+, K+, and Ca2+. Abbreviations: GLAST (EAAT1), glutamate/aspartate transporter; GLT1 (EAAT2), glutamate transporter; GLNT, glutamine
transporter; GluR, (metabotropic) glutamate receptor; NKA2/3, Na+, K+-ATPase α2-α3-subunit; NMDA, ionotropic glutamate receptor; NCX, Na
+,Ca2+-exchanger;
Gln, glutamine.
Figure 3), where the α2 Na+,K+-ATPase is functionally coupled
to glutamate transporters (Cholet et al., 2002; Rose et al., 2009),
may underlie the enhanced CSD susceptibility in the FHM2
mouse model (Leo et al., 2011). This has given rise to the
“glutamatergic” hypothesis. In the nervous system, the Na+,K+-
ATPase α2-isoform is expressed primarily in neurons during
embryonic development and at birth, but almost exclusively in
astrocytes in the adult (Moseley et al., 2003). Whereas neurons
express α1- and α3-subunits (with distinctly different subcellular
localization pattern, Juhaszova and Blaustein, 1997), astrocytes
express α1- and α2-subunits, and studies on primary cultured
rat astrocytes suggest, that the contribution of α2 to extracellular
K+ clearance is about 30% of total Na+,K+-ATPase activity
(Larsen et al., 2014). However, α1 and α2 are differentially
distributed in astrocytes. Whereas α1 is evenly present at the
plasma membrane, α2 rather shows a reticular distribution, like
the Na+,Ca2+-exchanger NCX1, where it may play an important
role in Ca2+ signaling (Juhaszova and Blaustein, 1997; see Section
ATP1A2 and Ca2+ Signaling), and it was found to be heavily
present in glial leaflets surrounding dendritic spines and axo-
dendritic synapses, where it colocalizes with GLAST and GLT-1
glutamate transporters (Cholet et al., 2002). This functional link
to glutamate transporters in astrocytic processes surrounding
glutamatergic synapses suggests specific roles in the regulation of
glutamate clearance (Pietrobon, 2007; Pietrobon andMoskowitz,
2013). However, ATP1A2 could have a crucial role in extracellular
K+ clearance by astrocytes (Larsen et al., 2014), similar to VSM
(DiFranco et al., 2015) and cardiomyocytes (Stanley et al., 2015).
Due to the stronger voltage-dependent inhibition of α2 pumps
(which is even augmented for the glial α2/β2 subunit composition
compared to α1/β1 pumps) and the lower extracellular K+
affinity, α2 pumps are essentially inactive at the normal, negative
resting potential and at normal extracellular [K+], whereas it will
be fully activated during cell depolarization and elevated K+. This
provides a substantial reserve pumping activity for K+ clearance
during strong cortical activity (Larsen et al., 2014). Yet, although
ATP1A2 is a key player in K+ clearance, this aspect has been
considered less important for the pathophysiology of migraine
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because the duration of the CSD was not prolonged in the
FHM2mouse model (Leo et al., 2011). These findings collectively
suggest that ATP1A2 mutations in migraine primarily cause
a disorder of glutamatergic neurotransmission with defective
regulation of the E/I balance in the brain (Pietrobon and
Moskowitz, 2013).
From CSD to Trigeminovascular
Nociception: The Neuroinflammatory
Hypothesis
CSD can be triggered by local elevations of extracellular [K+]
as a consequence of the hyperactivity of neuronal circuits in
the cerebral cortex. Of note, CSD is a slowly propagating wave
of strong neuronal and glial depolarization accompanied by
depression of electroencephalographic (EEG) activity and by a
large increase in extracellular [K+] (Pietrobon and Striessnig,
2003). To explain pain generation, the so-called vascular
theory prevailed in the past, which proposed that abnormal
dilation of meningeal and/or extracranial arteries causes pain,
since these are the only cerebral structures endowed with
primary pain receptors. However, clinical and experimental
evidence rendered this hypothesis implausible, since vasodilation
is neither necessary nor sufficient to cause migraine pain
(Pietrobon and Striessnig, 2003). It currently emerges that the
migraine headache depends on the activation and sensitization
of trigeminal nociceptors that innervate the meninges and their
large blood vessels. Mediators of noxious pain, such as protons,
nitric oxide, arachidonic acid, and serotonin, besides glutamate
and other neurotransmitters, are released during CSD. The
neuroinflammatory hypothesis suggests that these substances
may activate trigeminal nociceptors innervating blood vessels
in the pia mater, and, via axon collaterals, dural trigeminal
afferents and/or may slowly access the meningeal afferents after
disruption of the blood-brain barrier, thus eventually activating
central trigeminovascular neurons in the trigeminocervical
complex. Activation of the meningeal afferents leads to release
of proinflammatory vasoactive neuropeptides, e.g., the calcitonin
gene-related peptide (CGRP). These processes may promote
“sterile” neurogenic inflammation in the dura mater and sustain
the activation or sensitization of the trigeminovascular afferents
(Pietrobon and Striessnig, 2003).
ATP1A2 and Ca2+ Signaling
The concerted action between Na+,K+-ATPase and NCX1
is particularly important, since α2- and α3-isoforms (but
not α1) were found to co-immunoprecipitate with NCX1 in
rat brain membrane preparations. This, together with co-
localization studies by immunocytochemistry suggested that
plasma membrane microdomains containing NCX1 and Na+
pumps with α2- or α3-subunits in neurons and astrocytes form
Ca2+ signaling complexes with plasma membrane-subjacent
“junctional” endoplasmic reticulum (jER) microdomains
containing ryanodine receptors and sarco/endoplasmic
reticulum Ca2+-ATPase (Lencesova et al., 2004), as found
previously for the junctional sarcoplasmic reticulum (jSR)
microdomains in VSM cells as well as astrocytes (Juhaszova
and Blaustein, 1997). In line with this notion, it was shown on
primary cultured astrocytes from wild-type α2(+/+), knockout
α2(−/−), and α2(+/−) heterozygous mouse fetuses that graded
loss of ATP1A2 activity successively increases Ca2+ signaling
(Golovina et al., 2003). The typical volume of such a jS/ER or
“PLasmERosome” (Blaustein and Golovina, 2001) compartment
is sub-femtoliter in size, in which 1000 ions already account for
micromolar concentrations. As a consequence, a 50% loss in
Na+ pump activity may indeed be a matter of concern already
on short time scales.
Beyond the Glutamatergic Hypothesis: Cell
Volume as a Control Parameter?
One aspect attracting the attention of neurophysiologists is the
importance of cell volume changes that inevitably accompany
the massive changes in ion concentrations during seizures,
spreading depression, or anoxic depolarization. During CSD,
extracellular [K+] increases to 30–60mM, but extracellular
[Na+] and [Cl−] decrease to 50–70mM (Pietrobon and
Moskowitz, 2014). The concomitant massive uptake of Na+ and
Cl− by the Na+,K+,2Cl− transporter (NKCC1) of astrocytes
and simultaneous water uptake through aquaporins leads to
astrocyte swelling (Larsen et al., 2014). In this respect, it is
interesting to note that CSD can be optically monitored in
cortical preparations by measuring the so-called intrinsic optical
signal (IOS), a neuroimaging technique that measures cortical
reflectance changes with high temporal and spatial resolution.
The parameters, which the IOS is sensitive to, are changes in
light scattering, blood volume, oxy-/deoxyhemoglobin balance
and cytochrome oxidation (Ba et al., 2002). Light scattering
(monitored at 850 nm) is particularly sensitive to cell volume
changes, and this signal component coincides with the electrical
signal of the spreading wavefront. New modeling tools and
concepts in computational neuroscience have recently identified
cell volume as a critical control parameter that separates CSD
from seizures as well as other types of spreading depolarization
(Wei et al., 2014; Ullah et al., 2015). These approaches use
stunningly sophisticated models of neuronal excitability based
on a Hodgkin-Huxley-type framework of differential equations
that includes the activity of Na+,K+ ion pumps (Cressman
et al., 2009; Ullah et al., 2009), conservation of particles and
charge, and accounts for the energy required to restore ionic
gradients (Dahlem et al., 2013; Ullah et al., 2015). According
to Larsen et al. (2014), K+-induced swelling of astrocytes
is mediated by NKCC1, but NKCC1 does not contribute to
extracellular K+ clearance, an activity exclusively spared for
α2-containing Na+,K+-ATPase. Moreover, these authors found
indications that glial Na+,K+-ATPase acts to dampen cell
swelling during clearance of stimulus induced [K+]. So the
action of glial Na+,K+-ATPase could be four-fold: (1) direct
astrocytic K+ buffering and clearance, (2) glutamate clearance
(indirect via glutamate transporters), (3) osmolyte transport
to dampen cell swelling, and (4) direct repolarizing activity
due to electrogenic charge transport. Given the emphasis that
computational neuroscientists currently place on cell volume as
a control parameter discriminating between seizures and CSD
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(Ullah et al., 2015), it will be rewarding to study the relation
between Na+ pump dysfunction and cell volume regulation in
the CNS more closely by experiment and theory.
Computational neuroscientists outlined that the premonitory
symptoms of a migraine attack, such as the abnormal responses
to food, stress, or light, instead of mistaking them as trigger
factors themselves, should rather be considered as indicators of
a systemic transition at a culminating point that follows some
universal pattern, which is determined by dynamic network
biomarkers (DNBs) (Dahlem et al., 2013, 2014). In contrast to
traditional biomarkers (e.g., biochemical substances) that are
statically enhanced or increased in the pathological state, DNBs
are dynamical features of biological networks (also substances or,
in general, signals), which, though highly fluctuating, are strongly
correlated only during the premonitory phase. Such DNBs
characterizing the premonitory period are known for lung injury
disease, liver and lymphoma cancer, but still need to be identified
for migraine. However, their identification could help to develop
strategies for early therapeutic intervention. A new scientific
discipline, translational computational neuroscience, which still
needs to be inaugurated by close interactions between clinicians,
experimentalists and theoreticians, may fuse dynamical systems
theory with control theory in order to drive innovations in
therapeutic brain stimulation to treat neurological diseases based
on theoretical concepts (Dahlem et al., 2013).
THE WEAL AND WOE OF HAVING
Na+,K+-ATPase α2-SUBUNITS IN CERTAIN
TISSUES
What is the advantage of having different Na+,K+-ATPase α-
isoforms expressed in a tissue-specific manner, and which other
pathophysiological effects could be expected in the case of
α2-subunit haploinsufficiency besides the migraine phenotype?
Whereas the α1-isoform is ubiquitously expressed and most
indispensable for the organism, the α2-isoform is expressed
mainly in heart, skeletal, and vascular smooth muscle, brain,
lung, and adipocytes. The α3-isoform occurs mainly in neurons
and ovaries, as well as in developing hearts of rat and in adult
human heart and in white blood cells, and α4 is found in
sperm, where it is required for sperm motility (see Lingrel,
2010, and references therein). The possibility to coassemble
with three β-isoforms and up to seven FXYD proteins adds up
further complexity. The tissue and subcellular distribution of the
α2-isoform, in particular its selective expression in electrically
excitable cells, or the cells that surround them, or in VSM suggests
that α2 could also modulate excitability and contractility in heart
and skeletal muscle as well as in the vasculature (Radzyukevich
et al., 2004). The functional properties that distinguish α2- from
α1-containing Na+ pumps define the importance of this isoform
in muscle (DiFranco et al., 2015; Stanley et al., 2015) and
astrocytes (see Section From ATP1A2 Mutations to CSD: The
Glutamatergic Hypothesis). Stanley et al. showed recently that
the unusually steep voltage dependence of ion transport of α2-
containing Na+ pumps in the range of physiological potentials,
which is even exacerbated by assembly with β2, provides a strong
reservoir of pumping activity during the cardiac action potential,
while keeping it inactive at normal resting potentials. In addition,
as earlier found by Han et al. (2009), it was demonstrated
that α2 pumps in cardiomyocytes (Stanley et al., 2015) and
skeletal muscle (DiFranco et al., 2015) have reduced affinity
for extracellular K+, allowing them to be readily stimulated
by physiological rises in K+o occurring under exercise. The
distinct (cardiomyocytes) and almost exclusive (skeletal muscle)
localization of the α2-isoform to T-tubules (see DiFranco et al.,
2015; Stanley et al., 2015, and references therein), which are
highly diffusion-restricted spaces where K+o may rise to tens of
millimolar during muscle activity (DiFranco et al., 2015), further
supports the notion that α2 provides a safety net for K+o clearance
and Na+ extrusion that is only recruited on request.
Should cardiac, skeletal muscle or vasculature deficits
accompany the phenotype of ATP1A2 haploinsufficiency? In
the heart, the low (about 10–15%) overall proportion of the
α2-isoform and the presence of potentially compensating α1
in T-tubules may alleviate loss of α2 activity. Results from
transgenic animals seem to depend on the knockout strategy.
James et al. investigated a global germline deletion of one copy of
α2 (heterozygous α2(+/−) knockout mice) and observed cardiac
hypercontractility as a result of increased Ca2+ transients during
the contractile cycle, in accordance with the proposed role of
α2 in cardiac inotropy (James et al., 1999). Later, Rindler et al.
generated mice with tissue-targeted knockout of α2 that resulted
in more than 90% loss of α2 exclusively in the cardiovascular
system (Rindler et al., 2011) or in the heart (Rindler et al., 2013).
These authors found cardiac and vascular contractility unaltered.
Similar contrasting results were obtained regarding the effects
of α2 knockouts in the vasculature, in which the ratio of α2
to α1 is 30%/70% (Shelly et al., 2004). Whereas heterozygous
α2(+/−) knockout mice had elevated systolic blood pressure,
increased myogenic tone and arterial contractility (Shelly et al.,
2004; Rindler et al., 2011), the cardiovascular knockout model
showed normal basal blood pressure and vascular contractility
suggesting that expression of α2 in cardiac myocytes and vascular
smooth muscle is not involved in the regulation of basal blood
pressure. Possibly, α2 in another cell type might be responsible
for the hypertension observed in global α2(+/−) mice (Rindler
et al., 2011). In rare cases, vascular abnormalities coincide with
hemiplegic migraine, such as pulmonary arterial hypertension
(Montani et al., 2013) and reversible cerebral vasoconstriction
(Hermann et al., 2013).
The situation should definitely be different in skeletal muscle,
in which α2 comprises nearly 90% of total α-subunit content
(He et al., 2001) and is almost exclusively present in T-tubules
(DiFranco et al., 2015). However, the α2-isoform does not set
resting ion gradients (He et al., 2001) or the resting potential
(Radzyukevich et al., 2004, 2013) in skeletal muscle, the canonical
roles of the Na+,K+-ATPase in most other cell types, due to
its profound voltage-dependent inhibition at the about −90mV
resting potential in skeletal muscle and its lower K+ affinity
compared to α1. In accordance, the α1-isoform localized to the
surface sarcolemma provides up to 75% of the basal Na+,K+
transport needed to stabilize ion gradients and membrane
potential at rest. However, α1 operates at the upper edge of
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its regulatory range for activation by K+, and the tremendous
transport capacity of α2 pumps needs to be recruited during
exercise. Skeletal muscle also differs from other excitable tissues
because its resting potential is set by ClC chloride channels
(Pedersen et al., 2016), as illustrated by the hyperexcitability of
skeletal muscle in myotonia congenita, a muscle disease resulting
from loss-of-function mutations in the ClC-1 gene (Koch et al.,
1992). Also for skeletal muscle effects, studies on transgenic
mice are not fully conclusive. Whereas increased isometric force,
hypercontractility and increased fatique was observed in isolated
skeletal muscle from heterozygous α2(+/−) mice (He et al.,
2001), the α2(+/−) animals themselves did not fatique faster than
wild-type animals (Moseley et al., 2007). Increased fatique was
observed in skeletal muscle-targeted α2(+/−) knockout animals
and muscle preparations derived thereof (Radzyukevich et al.,
2013). Of note, a 2.5-fold upregulation of α1 was observed
in these skeletal muscle α2(−/−) knockout animals, and even
some presence of α1 in T-tubules was observed suggesting that
some partial compensation by α1 could take place (Radzyukevich
et al., 2013). Since the largest effects were observed in the severe
skeletal muscle knockout system but not in the global α2(+/−)
heterozygotes, it seems plausible that the vast capacity of α2
to cope with tremendous physiological load increases during
physical exercisemay keep sufficient reserve at hand that 50% loss






For the investigation of functional consequences of FHM2
mutations, the so-called ouabain survival assays on HeLa cells are
most frequently applied (Bassi et al., 2004; de Vries et al., 2007).
The mutations are introduced into an ouabain-resistant ATP1A2
backbone carrying the Q116R/N127D double mutation in the
TM1-2 loop, which produces IC50 values in the 100 micromolar
range (Price and Lingrel, 1988). HeLa cells are either transiently
or stably transfected and put under micromolar ouabain stress,
which is sufficient to block the endogenous Na+ pumps, so that
only cells expressing an ATP1A2mutant construct with sufficient
residual activity can survive. The heterozygous state of patients
can be mimicked by co-transfecting equal amounts of wild-
type and mutant ATP12A2 DNA in order to address possible
dominant-negative effects (De Fusco et al., 2003). The cell line
for transfection should be carefully chosen as highlighted by the
differences observed from ouabain survival assays on COS7 and
HeLa cells for the W887R mutation (De Fusco et al., 2003; Leo
et al., 2011). Whereas the mutant protein did not confer cell
survival in both cell lines, (De Fusco et al., 2003) reported normal
cellular distribution and plasma membrane expression in COS7
cells, but (Leo et al., 2011) found drastically reduced protein level
and a mainly intracellular distribution in HeLa cells suggesting
that COS7 cells might be prone to saturation artifacts, a common
threat in transient transfection studies.
Biochemical Assays
Molecular function can be addressed by biochemical assays,
which requires recombinant protein production in appropriate
expression hosts such as stably transfected mammalian cells
(Toustrup-Jensen et al., 2014), or insect cells (e.g., Sf9 derived
from the fall armyworm Spodoptera frugiperda, Weigand et al.,
2014b). Yeast cells (Pichia pastoris) have also been used (Cohen
et al., 2005), but this host has not yet been employed for the study
of FHM2 mutations. Subsequently, the whole set of biochemical
techniques can be performed (see Glynn, 1985; Kaplan, 2002,
for reviews), such as the “classical” ATPase (Skou, 1957) or
phosphorylation assays, in which also the effects of different Na+
and K+ concentrations, the steady-state phosphoenzyme level,
conformational preference, ouabain binding and sensitivity,
and vanadate sensitivity can be determined. The maximum
phosphorylation levels obtained in the presence of oligomycin
are used to measure the concentration of active enzyme sites,
which, together with ATP hydrolysis rates, are used to determine
the maximum turnover number (Glynn, 1985; Vilsen, 1995), thus
yielding a thorough characterization of enzymatic properties.
Electrophysiological Assays:
The Two-Electrode Voltage Clamp
The cation transport function of the Na+,K+-ATPase as such can
only be investigated in intact cells, which maintain the extra-
/intracellular sidedness of substrate access and allow for the
application of a membrane (or more general: electrochemical)
potential load on cation transport. Na+,K+ transport and the
most significant properties relating to the electrogenicity of
the Na+ pump are determined by electrophysiology, mostly by
applying the two-electrode voltage clamp technique on oocytes
from the frog Xenopus laevis (Stühmer and Parekh, 1995). This
technique allows one to study the dependence of Na+,K+ pump
currents on extracellular [K+], [Na+], ouabain and voltage, so
that the complex interplay between Na+ and K+ at the externally
facing cation binding sites can be analyzed.
Typical Na+,K+ pump currents, as can be recorded with
the two-electrode voltage clamp on Xenopus laevis oocytes, are
shown in Figure 4A together with the voltage and extracellular
[K+] dependence (Figure 4B), from which K0.5(K+) values
for half-maximal pump current stimulation can be determined
(Figure 4C), which symbolize the voltage dependence of the
enzyme’s apparent affinity for extracellular K+.
In the absence of extracellular K+ and at high extracellular
[Na+], the enzyme is restricted to the partial reaction sequence
underlaid in yellow in Figure 1 that accounts for ouabain-
sensitive “transient” currents in response to voltage pulses
(Figure 5A). Extracellular release of Na+ ions occurs in three
distinct steps, from which only the deocclusion and release
of the first Na+ ion is major electrogenic (Holmgren et al.,
2000). This step is rate-limited by the preceding (presumably
non-electrogenic) E1P→E2P conformational change and cation
deocclusion, which gives rise to the startling observation that the
forward rate constant for Na+ release is not voltage-dependent
(see the flat progression of rate constants in Figure 5B at positive
voltages). However, in the reverse direction, the reverse binding
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FIGURE 4 | Stationary Na+/K+ pump currents of the Na+,K+-ATPase (human ATP1A2) from two-electrode voltage clamp experiments on X. laevis
oocytes. (A) Pump currents in response to different extracellular [K+] at −30mV holding potential, (B) I-V curves for different [K+]ext at high [Na+]ext (100mM). (C)
K0.5(K
+ext) values from fits of a Hill function to the [K+] dependent pump current amplitudes at different potentials from (B).
of Na+ ions from the extracellular side induced by negative
voltage pulses occurs with a strongly voltage-dependent rate
constant (see the steeply rising rate constants in Figure 5B at
negative voltages). Following release of the first Na+ ion, the
high-field access channel to the other Na+ occlusion sites is
restructured such that the exit of the remaining two Na+ ions
contributes only little to the overall electrogenicity. In terms of
the “access channel” model, positive voltage pulses drive Na+
ions extracellularly out of the access channel resulting in ouabain-
sensitive “transient” currents with positive polarity. Conversely,
negative voltage pulses promote the reverse binding of Na+ ions
to the binding sites in E2P and induce negative transient currents
(Figure 5A). Due to the electrogenicity of reverse binding of
extracellular Na+, the occupancy of the Na+ binding sites is
controlled by [Na+]o and voltage. The amount of charge moved
in response to a certain voltage stepQ(V) follows a characteristic,
sigmoidal, Boltzmann-type function (see Figure 5C):






which is used to fit the experimentally obtained Q(V) curves.
Here, Qmin and Qmax are the saturation values of Q(V), F is
the Faraday constant, R the molar gas constant, T the absolute
temperature in K, V the membrane voltage, and zq the slope
factor or equivalent charge. This distribution is centered at a half-
maximal voltage (V0.5), at which 50% of Na+ binding sites of
the pump molecules are occupied. Since the Na+ uptake/release
steps are kinetically coupled to the E1P←→E2P conformational
transition, 50% of the enzyme molecules are in E2P and 50%
are in E1P at this stage. Thus, the V0.5 value at a given [Na+]o
is a characteristic parameter for each Na+,K+-ATPase isozyme
(or mutant), and since V0.5 shifts with the extracellular [Na+],
changes in V0.5 induced by mutations indicate changes in the
apparent affinity for Na+o . Positive shifts of V0.5 indicate an
increased apparent Na+ affinity and vice versa.
The equivalent charge zq indicates the electrogenicity of the
Na+ transport step, i.e., which fraction of the transmembrane
field is “sensed” by a unitary charge moved or, conversely, which
fraction of a charge encounters the full transmembrane field
during an elementary charge-moving event.
Of late, the ouabain-sensitive leak currents are investigated
by electrophysiology as well, since mutations interfering with a
C-terminal access pathway for protons drastically affect cation
affinities (Morth et al., 2007; Poulsen et al., 2010). Thus, especially
C-terminal mutations identified in FHM2 and AHC have been
scrutinized for suspicious leak current activity (Poulsen et al.,
2010; Li et al., 2015). As an example, the leak currents of the Na+
pump that occur upon deletion of the two C-terminal tyrosines of
the α-subunit are shown in Figure 6. Figure 6A shows ouabain-
sensitive transient currents of the ATP1A2-1YY mutant in the
absence of extracellular K+ and [Na+]o = 100mM (Meier et al.,
2010). Compared to the transient currents of the WT enzyme
(Figure 5A), the “ON” transient currents of the mutant do not
decay to zero at negative voltages, but a steady inward current
results, which is augmented with increasing [Na+]o (Figure 6B).
This phenomenon was also observed by Yaragatupalli et al.
(2009), Poulsen et al. (2010) and Vedovato and Gadsby (2010).
ATP1A2 MUTATIONS CORRELATED WITH
CLINICAL MIGRAINE CASES
To date, about 81 ATP1A2 mutations have been reported in
migraine-correlated neurological disease cases in the literature.
A complete list is provided in Supplementary Table 1 together
with information about the diagnosed diseases, the location of
the mutated residues within the structure of the Na+,K+-ATPase
(see Figure 2) and, if available, a brief summary of functional
consequences of the mutations. The vast majority (about 60)
of the mutations were classified as FHM. Moreover, about
25 mutations were diagnosed in sporadic cases of hemiplegic
migraine, SHM, (with overlap in the case of G815R, R908Q,
P979L, which were identified in different unrelated pedigrees or
individuals) showing that mutations in the ATP1A2 gene locus
substantially account for de novo mutations causing hemiplegic
migraine. About 10% of ATP1A2 mutations were identified
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FIGURE 5 | Properties of ouabain-sensitive transient currents of the Na+,K+-ATPase. (A) Transient currents evoked by pulses from −30mV to voltages
between +60 and −140mV in −40mV decrements measured on human ATP1A2 in two-electrode voltage clamp experiments on X. laevis oocytes (“ON” currents),
and from pulses back to −30mV (“OFF” pulses). (B) Reciprocal time constants from fits of a single exponential function to the current traces in (A). (C) Q(V)
distribution from the improper integrals of the transient current signals (“OFF” pulses) from (A) with the parameters obtained from fits of a Boltzmann-type function to
the data. The Q(V) distribution from “ON” transient currents would be obtained by multiplying the above curve with (−1).
FIGURE 6 | Leak currents of the Na+,K+-ATPase upon mutation of the α-subunit’s C-terminus. (A) Ouabain-sensitive transient currents measured at
[K+]o = 0, [Na+]o = 100mM (pH 7.4) upon pulses from −30mV to voltages between +60 and −140mV in −40mV decrements for mutant ATP1A2-1YY in
two-electrode voltage clamp experiments on X. laevis oocytes (“ON” currents), and from pulses back to −30mV (“OFF” pulses). (B) [Na+]o dependence of the
current-voltage curves of the steady-state inward leak currents (closed symbols), the leak currents of the WT enzyme at zero [Na+] are shown as open squares.
in migraine with or without aura (MA/MO) indicating that
the gene might also be a susceptibility locus for common
forms of migraine (Todt et al., 2005). An overlap with epilepsy
or seizures has been noted in about 15% of cases. Of note,
two ATP1A2 mutations were identified in patients with AHC,
such as the I589T mutation reported in an atypical case of
AHC (Al-Bulushi et al., 2014), and T378M, which was found
in two families, either correlated with FHM (Bassi et al.,
2004) or with AHC (Swoboda et al., 2004). Other pathologies
associated with ATP1A2 mutations were sensorineural hearing
loss (V191M, Oh et al., 2015), basilar migraine (R548H,
Ambrosini et al., 2005), benign familial infantile convulsions
(BFIC; R689Q, Vanmolkot et al., 2003), generalized epilepsy with
febrile seizures (GEFS+; G874S, Costa et al., 2014), pulmonary
arterial hypertension (S940L, Montani et al., 2013) and reversible
cerebral vasoconstriction (P979L Hermann et al., 2013).
Within the Na+,K+-ATPase crystal structure, more than 80%
of mutations fall into four spatially distinct clusters, one around
the catalytic P domain, one in a central region between P and
TM domain, one within the extracellular-facing part of the TM
domain, and one around the enzyme’s C-terminus (Figure 2),
which are all regions of critical importance for function. About
75% of the reported ATP1A2 mutations have been scrutinized
for function at different levels of experimental sophistication
(Supplementary Table 1).
Functional Studies: Mildly and Severely
Deleterious ATP1A2 Mutations
Among the ATP1A2 mutations studied so far, some stand out
because only mild consequences were observed (Supplementary
Table 1). These include mutations at the enzyme’s N-terminus,
Y9N (SHM) and R51H (MO), which behaved similar to WT
in biochemical studies on Sf9 cell membrane preparations
(Swarts et al., 2013). A clue for the physiological consequences
can be inferred from Song et al. (2006), who showed that
ATP1A2 and ATP1A3 share an N-terminal targeting sequence
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within amino acids 1–90, which is apparently responsible for
localization to jS/ER compartments in primary cultured mouse
astrocytes. It remains to be clarified whether the N-terminal
mutations of ATP1A2 interfere with targeting in order to decide
whether or not these mutations are rare missense variants
without pathogenic effects. The same accounts for E174K (MO),
which was inconspicious in electrophysiological experiments on
Xenopus oocytes and showed only mildly reduced activity in Sf9
cell preparations (Todt et al., 2005; Swarts et al., 2013), although
the mutation inverts the charge of a highly conserved residue
in the A domain, which might form a salt bridge with Lys-
432 in the N domain important for inter-domain interactions.
Very similar observations were reported for the E902K (FHM)
mutation, which showed electrophysiological properties like the
WT enzyme (Spiller and Friedrich, 2014), but reduced ATPase
activity and ouabain binding in Sf9 cell membrane preparations
(Swarts et al., 2013). Also for K1003E (SHM+seizures) and
R1007W (FHM), only mild consequences were reported from
electrophysiology on Xenopus oocytes (Pisano et al., 2013; Spiller
and Friedrich, 2014), despite the charge inverting/neutralizing
effect.
At the other end of the functional spectrum, mutations
that lead to a premature stop codon, a frame shift or
a deletion/insertion are expected to cause severe functional
disruptions. These include K95del (FHM & epilepsy), F305del
(SHM), R834X (FHM), del(K935-S940)insI (FHM), S966fs
(FHM), L944del (SHM+focal seizures), and Y1009X (SHM),
which all classify as familial or de novo mutations causing
hemiplegic migraine, frequently with severe accompanying
symptoms and, as far as functional studies are available, lead
to complete loss of function and/or loss of plasma membrane
targeting.
The remaining mutations, which entail loss or drastic
reduction of activity, are depicted in Figure 7. These mutations
mostly locate to the P domain and the extracellular TM domain
cluster, with only a few others in the N domain (T415M, C515Y,
R548H) and two in the central cluster (L764P, R937P). Mutation
G301R (identified in two FHMkindreds) showed slightly reduced
plasma membrane expression but no pumping activity in the
Xenopus oocyte system, indicating reduced protein stability and
complete loss-of-function (Tavraz et al., 2009). In HeLa cells,
however, the mutant showed strongly reduced cell viability in
ouabain survival assays, no plasma membrane expression and no
protein detectable in Western blots (Santoro et al., 2011). The
structure-destabilizing and functional disruption effect can be
attributed to the insertion of a bulky, charged side chain within
the center of the block of TM helices close to one of the common
cation binding sites.
T376M (FHM) and T378N (FHM,AHC) affect two threonines
in the 373SDKTGTLT380 motif around the intermediately
phosphorylated Asp-374. Although the mutant proteins were
expressed similar to theWT enzyme in Xenopus oocytes (T376M,
Tavraz et al., 2008) and HeLa cells (T378N, Bassi et al., 2004),
no pump activity or cell survival was observed. T415M (FHM)
and C515Y (MA) affect two highly conserved residues at the
periphery of the N domain, for which effects on function are
difficult to infer. Nevertheless, the T415M mutant did not confer
FIGURE 7 | Location of ATP1A2 mutations with most severe
consequences on function. Mutated amino acids, for which functional
consequences are described in the text, are shown in stick representation.
Mutant P979L was shown to be fully functional in the Xenopus oocyte system,
whereas temperature-dependent effects on protein stability and plasma
membrane targeting were observed in mammalian cells (Tavraz et al., 2008,
2009).
cell viability in ouabain survival assays despite normal protein
level (Vanmolkot et al., 2007), and the C515Y mutation entailed
strongly reduced pump currents and ATPase activity in Xenopus
oocytes (Todt et al., 2005). Inter-domain interactions are also a
critical concern for the R584H (basilar migraine/MA) and R548C
(FHM) mutations, since Arg-548 likely forms a salt bridge with
Glu-221 that stabilizes the interaction between the A and N
domains in the E2P conformation, but probably forms another
salt bridge to the β-phosphate of ATP. Although ATP affinity
was not changed for mutant enzymes prepared from Sf9 cells,
strongly reduced ATPase activities were observed (Swarts et al.,
2013) indicating that the structure-coordinating effect of the salt
bridge might be critical.
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Mutations R593W and V628M were both identified in FHM
and showed strongly reduced cell viability in ouabain survival
assays with normal protein level (Vanmolkot et al., 2006a), and
R593W exhibited strongly reduced ATPase activity and reduced
phosphoenzyme level in COS-1 cell membranes (Schack et al.,
2012). Arg-593 is located at the border of the P domain, directly
after two prolines that form the hinge between the P and N
domains. The residue is within hydrogen bonding distance of
the backbone carbonyls of Gly-377 and Thr-378, which are
located in the same loop as Asp-374 and Thr-376 indicating
that the steric clash resulting from insertion of the tryptophan
might disturb phosphorylation (Vanmolkot et al., 2006a; Schack
et al., 2012). Val-628 resides in the P domain and is located
at the border of the short, conserved P3 helix that together
with the seven-stranded parallel β-sheet forms the typical
Rossmann fold implicated in nucleotide binding suggesting an
impact on catalytic activity (Schack et al., 2012). The G615R
mutation, which was identified in FHM with particularly severe
accompanying symptoms and in a patient with SHM, affects the
glycine in the critical 612MVTGD616 structure motif in the P
domain, which rationalizes that the mutation has been found to
be deleterious for cell viability (Vanmolkot et al., 2006b).
The M731T mutation was functionally assessed by several
groups (Capendeguy and Horisberger, 2004; Segall et al., 2005;
Schack et al., 2012), with the most stringent study carried out on
the human ATP1A2 enzyme (Schack et al., 2012), whereas the
other two studied rat ATP1A2 (Segall et al., 2005) or ATP1A1
from Bufo marinus (Capendeguy and Horisberger, 2004). All
studies converged on the notion of strongly reduced ATPase
activity or loss of pump function. For efficient phosphorylation,
the loop between β-sheet 6 and helix P7 of the Rossmann fold, in
which Met-731 is located, has to be strained upon Mg2+ binding.
Thus, the role of Met-731 may be to reduce the mobility of this
loop to ensure the strain. Met-731 is also flanked by Arg-593 (see
above), and the mutation might prevent proper bending of the P
domain (Schack et al., 2012).
Mutations L764P andW887Rwere identified in the first report
on FHM2 (De Fusco et al., 2003). L764P inserts a structure-
breaking proline into the central helix TM5, which connects the
phosphorylation site to the cation-binding pocket. The P786L
(SHM) mutation also affects a residue on the extracellularly-
oriented part of the TM5 helix. In accordance with the critical
role of TM5, all studies investigating the effects of the TM5
mutations showed severe or complete loss of catalytic activity
(Koenderink et al., 2005; Swarts et al., 2013) or cell survival (De
Fusco et al., 2003; de Vries et al., 2007). The 796P796S799 (FHM)
mutation, which affects a proline within the conserved PLPL turn
connecting TM5 and TM6, also did not support cell survival
(Castro et al., 2008) or ATPase activity in Sf9 cell membranes
(Weigand et al., 2014b).
The W887R mutant also did not confer cell survival (De
Fusco et al., 2003), showed no pump currents (Capendeguy and
Horisberger, 2004; Koenderink et al., 2005) and strongly reduced
Rb+ uptake, despite normal plasma membrane expression in
Xenopus oocytes (Koenderink et al., 2005). From the structure,
it is difficult to rationalize a loss of functional activity by this
mutation. Trp-887 is located within the TM7-8 loop important
for interaction with the β-subunit, but is not directly involved
(Nyblom et al., 2013). If the interaction with the β-subunit were
disrupted, a defect in membrane insertion and protein folding
accompanying biosynthesis in the ER could be expected, with
consequently reduced plasma membrane targeting, but this was
not observed in the expression systems studied. Furthermore, the
defective ouabain binding of the W887R mutant (Koenderink
et al., 2005) is puzzling since Trp-887 was not implicated in
ouabain binding. However, it was found in a mouse model for
FHM2 that the mutant ATP1A2 protein was hardly detectable
in the brain of homozygous ATP1A2(W887R/W887R) mutants
and strongly reduced in ATP1A2(+/W887R) heterozygous
mutants (Leo et al., 2011). In transfected HeLa cells,
these authors also found profound protein loss, likely as
the consequence of endoplasmic reticulum retention and
subsequent proteasomal degradation. This finding contrasts
with observations from the aforementioned study on transfected
COS7 cells (De Fusco et al., 2003) indicating that it is important
to avoid saturation effects in cell line used for transfection
(Leo et al., 2011).
Mutation G855R (FHM+febrile seizures) did not confer
cell survival (de Vries et al., 2009) or pump currents in the
Xenopus oocyte system (Spiller and Friedrich, 2014), which in the
latter system coincided with strongly reduced plasma membrane
protein level. Gly-855 resides within TM7, a helix forming
multiple contacts to the TM of the β-subunit (Nyblom et al.,
2013), but Gly-855 is not directly involved in helix-helix contacts.
However, due to the close packing of the helices, the introduction
of a bulky side chain can indirectly affect the interaction with
the β-subunit, which appears likely since the defective plasma
membrane expression suggests improper folding and premature
degradation.
Mutation R937P (FHM) did not show pump currents or
Rb+ uptake in an initial study on Xenopus oocytes (Tavraz
et al., 2008), and no ATPase activity in Sf9 cell membranes
(Weigand et al., 2014b). However, based on the knowledge about
the involvement of Arg-937 in coordinating the α-subunit’s C-
terminus, its link to Na+ binding site III and the reported effects
on Na+ affinity (Toustrup-Jensen et al., 2009), it could be shown
by electrophysiology that the mutation caused enhanced proton
“leak” currents and a drastic negative shift of theQ(V) curve from
transient currents (Poulsen et al., 2010), in line with a drastically
reduced apparent affinity for extracellular Na+. In effect, the
R937P mutant still retains some essential properties of the Na+
pump, albeit with severely changed voltage dependence and
enhanced proton leak, but the properties of the mutant’s Na+,
K+ pump currents have still to be elucidated. R937P is so far the
only FHM2 mutation that shows increased proton leak currents.
Work by the Artigas and Gadsby labs showed that pump-
mediated proton current is an intrinsic property of Na+,K+-
ATPase (Mitchell et al., 2014; Vedovato and Gadsby, 2014) at
physiological K+ and Na+ concentrations and resting potentials
suggesting that this “hybrid” transporter function may well have
been exploited by nature for some physiological purpose. It still
remains to be established whether Na+,K+-ATPase-mediated
proton uptake plays any physiological or pathological role (see
Section Functional Properties of the Na+,K+-ATPase).
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P979L is a particularly interesting mutation, which was reported
to cause FHM2 in one of the earliest accounts on the genetic
background of the disease (Jurkat-Rott et al., 2004), and, later,
also in a case of SHM (Hermann et al., 2013). Comorbidities were
serious, since the first report listed particularly severe attacks
accompanied by recurrent coma and tonic-clonic seizures,
whereas the SHM patient suffered from prolonged aura phase
and severe reversible cerebral vasoconstriction.Within the crystal
structure, Pro-979 is located within the TM9-10 loop and the
protein backbone kink induced by the proline may be important
for protein folding. However, when assayed by electrophysiology
in Xenopus oocytes, all functional parameters were identical
to those of the WT enzyme, with normal total and plasma
membrane protein levels (Tavraz et al., 2008). However, in
surface biotinylation assays on transfected HEK293FT cells, it
was later found that the amount of P979L protein was strongly
reduced, when the cells were incubated at 37◦C, but not upon
cell incubation at 28◦C (Tavraz et al., 2009). This discrepancy
highlights the influence of the model cell system used. Xenopus
oocytes are kept at 18–20◦C, a temperature range, which is
advantageous for protein folding, whereas mammalian cells are
grown at 37◦C, where protein instability might lead to misfolding
and degradation. The situation is reminiscent of observations
on the epithelial CFTR Cl− channel mutated in cystic fibrosis
(CF). The most common CF mutation, the1F508 deletion, leads
to rapid degradation of the protein before exiting the ER in
mammalian cells (kept at 37◦C), while the mutant protein could
be functionally expressed in Xenopus oocytes. It could be shown
that this effect is temperature-sensitive since protein degradation
can be rescued at permissive temperature (Denning et al., 1992).
SUMMARY AND PERSPECTIVES
The detailed atomic-scale understanding of ion transport
and catalysis of the Na+,K+-ATPase provided by the wealth
of structural data together with the multi-modal efforts of
numerous experimentalists have provided a rather stringent
concept of the effects of migraine-associated ATP1A2 mutations
on molecular function. While the spectrum of functional
disruptions matches the complexity of the Na+ pump’s inner
workings and the enzyme’s even more complex integration
into cellular signaling networks, the notion emerges that loss
or change of any kind of functional parameter, including the
seemingly subtle changes in voltage dependence could be of
pathophysiological relevance. This is because for any of these
alterations, pathophysiological conditions are conceivable that
render these changes critical for controlling the excitability
of electrically excitable tissues. Two seemingly self-evident but
oversimplifying conclusions should be avoided: First, changes in
Na+ pump function brought about by disease-related mutations
do not converge on a simple loss-of-function concept. While
this is certainly true for mutations abolishing Na+,K+ pumping,
a change in voltage dependence may entail loss-of-function
in a particular voltage range, but gain-of-function in another.
Furthermore, given the controversy about whether proton leak
currents are part of the Na+ pump’s physiological spectrum
of functions, both, reduced proton leaks (loss-of-function, as
discussed for the E815K mutation in ATP1A3 in AHC) as well as
increased proton leaks (gain-of-function, as discussed for somatic
ATP1A1 mutations in APA) could be causative for one or the
other pathophysiological state. Second, the CSD phenomenon
is not simply the consequence of either cortical hypo- or
hyperexcitability. Rather, it emerges that the reduced ability to
dynamically maintain the cortical excitatory/inhibitory balance
and the failure to prevent excessive increases in cortical excitation
mechanistically explain the abnormal sensory processing in
migraineurs.
While it is commonly accepted that functional changes in
FHM-related genes including those in ATP1A2 converge on CSD
as the neurophysiological correlate of migraine aura, the link
to the most disabling condition of the disease, the throbbing
migraine pain, is still a matter of debate. Currently, the view
emerges that CSD can cause sustained activation of meningeal
nociceptors and central trigeminovascular neurons to initiate
the headache mechanisms in a process termed sterile meningeal
inflammation. Moreover, the physiological control parameters
discriminating between the propagation speeds of rapid (epileptic
seizures) or slow (CSD) waves of cortical hyperexcitation need
to be investigated in more detail to identify critical network
parameters for or by in silico modeling of excitable biological
matter. In this context, knowing the parameters of dysfunction
of mutated ion pumps and channels of the CNS may help
to identify the elements that count. The remarkable progress
achieved by computational neuroscientists who have just recently
put forward the idea that cell volume regulation is critical
for determining whether an excitable tissue may evolve into
seizures or spreading depression, provides novel hypotheses to
be tested by experiment. This should encourage synergistic,
cross-disciplinary collaborations between researchers studying
excitable matter on the clinical, in vivo, in vitro, and in silico level.
In order to classify an ATP1A2 mutation as causative for
a disease, at least the simplest test should be performed, an
ouabain survival assay in mammalian cells. For the assessment
of enzyme catalysis, biochemical studies on protein preparations
from mammalian cell lines or Sf9 cells provide exhaustive tools
of characterization. However, elucidation of the most essential
physiological function, electrogenic Na+,K+ transport, requires
dedicated electrophysiological assays on intact cells. For this
purpose, the Xenopus oocyte expression system is a versatile tool,
since it permits electrophysiology as well as cation uptake assays,
and some means of fundamental protein biochemistry. Whereas
electrophysiology on oocytes is indispensible for researchers
interested in understanding Na+ pump function in molecular
detail, the Xenopus system is less physiological when it comes to
effects on protein expression, stability or targeting, as the example
of the P979L mutant and others noted in this work have shown.
Thus, as a rule of thumb, the observed functional consequences
should ideally be cross-checked in at least two different cell
systems in order to avoid both false-positive and false-negative
conclusions.
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